Tag: Seiji Hirasaki
Moderna to acquire Oriciro Genomics
Moderna, Inc, a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and OriCiro Genomics K.K., a pioneer in cell-free DNA synthesis and amplification technologies, recently announced they have entered into a definitive agreement through which Moderna will acquire OriCiro for $85 million.
Featured Article
GridBeyond highlights role of technology in navigating energy market swings
Energy price volatility continues to pose challenges for manufacturers and other energy-intensive industries, particularly as electricity markets experience more frequent and unpredictable price swings.
